| Conference welcome and Keynote Introduction | |||||
|
Tue18 May09:45am(5 mins)
|
|
Johan Hyllner | |||
| Session : Welcome and Keynote Presentation | |||||
| Room: Conference Hall | |||||
| Keynote: Combined cell and gene therapy for Epidermolysis Bullosa | |||||
|
Tue18 May09:50am(45 mins)
|
|
Prof Michele De Luca | |||
| Session : Welcome and Keynote Presentation | |||||
| Room: Conference Hall | |||||
| Cellular reprogramming to enable the consistent and scalable manufacturing of human cells for therapeutic applications | |||||
|
Tue18 May10:35am(30 mins)
|
|
|
Dr Alex Davenport | ||
| Session : Welcome and Keynote Presentation | |||||
| Room: Conference Hall | |||||
| Session Chair Welcome | |||||
|
Tue18 May11:25am(5 mins)
|
|
Johan Hyllner | |||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Developing a stem cell based therapy for Parkinson’s disease | |||||
|
Tue18 May11:30am(20 mins)
|
|
Prof Malin Parmar | |||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Overcome the most common challenges in cell & gene therapy development using Droplet Digital PCR | |||||
|
Tue18 May11:50am(15 mins)
|
|
|
Rosario Tizzone | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Cartilage regeneration with cell therapy - current and future aspects | |||||
|
Tue18 May12:05pm(20 mins)
|
|
|
Prof Anders Lindahl | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Tue18 May12:30pm(20 mins)
|
|
Prof Malin Parmar |
|
Prof Anders Lindahl | |
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Single Cell Multiomics to Accelerate Cancer Immune Cell Therapy Research | |||||
|
Tue18 May12:50pm(15 mins)
|
|
|
Stephen Hague | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Efficient and automated single-cell cloning with iotaSciences' cloning platform | |||||
|
Tue18 May01:05pm(5 mins)
|
|
|
Dr Ann Na Tan | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Session Chair Welcome | |||||
|
Tue18 May02:10pm(5 mins)
|
|
Dr Ryan Hicks | |||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Is the Cellular Secretome the Next Step of Cell Therapy? | |||||
|
Tue18 May02:15pm(20 mins)
|
|
|
Philippé Menasché | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Streamline and modernise your Immunology and Immuno-Oncology research | |||||
|
Tue18 May02:35pm(30 mins)
|
|
|
Dr Suzanne Riches | ||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| VEGF-A modified mRNA in Cardiovascular Disease | |||||
|
Tue18 May03:05pm(20 mins)
|
|
Anna Collén | |||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Regenerative Medicine in Diabetes: a work in progress | |||||
|
Tue18 May03:30pm(20 mins)
|
|
Prof Lorenzo Piemonti | |||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Tue18 May03:50pm(20 mins)
|
|
Philippé Menasché |
|
Anna Collén | |
|
|
Prof Lorenzo Piemonti | ||||
| Session : Cell based therapies across disease areas - Sponsored by Iota Sciences | |||||
| Room: Conference Hall | |||||
| Conference welcome and Keynote Introduction | |||||
|
Wed19 May09:45am(5 mins)
|
|
Prof Stephan Mielke | |||
| Session : Welcome & Keynote Introduction | |||||
| Room: Conference Hall | |||||
| Keynote: CAR-T Cell Therapy for Multiple Myeloma | |||||
|
Wed19 May09:50am(45 mins)
|
|
Prof Hermann Einsele | |||
| Session : Welcome & Keynote Introduction | |||||
| Room: Conference Hall | |||||
| Translating Cellular Reprogramming into Efficacious and Scalable Cell Therapies for Immuno-Oncology | |||||
|
Wed19 May10:35am(30 mins)
|
|
|
Dr Alessandra De Riva | ||
| Session : Welcome & Keynote Introduction | |||||
| Room: Conference Hall | |||||
| Session Chair Welcome | |||||
|
Wed19 May11:25am(5 mins)
|
|
Prof Stephan Mielke | |||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| Autologous NK Cells as Consolidation Therapy in Multiple Myeloma | |||||
|
Wed19 May11:30am(20 mins)
|
|
|
Prof Hans-Gustaf Ljunggren | ||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| Proteins and Reagents for Cell and Gene Therapy Research | |||||
|
Wed19 May11:50am(15 mins)
|
|
|
Deborah Moore-Lai | ||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| Stem cell transplantation as a backbone for modern cell- and gene therapy | |||||
|
Wed19 May12:05pm(20 mins)
|
|
Prof Stephan Mielke | |||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Wed19 May12:30pm(15 mins)
|
|
Prof Stephan Mielke |
|
Prof Hans-Gustaf Ljunggren | |
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| The use of capillary electrophoresis in gene therapy product testing | |||||
|
Wed19 May12:45pm(15 mins)
|
|
|
Dr Stephen Lock | ||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
| Nanofibrillar Cellulose (NFC) Hydrogel for Regenerative Medicine | |||||
|
Wed19 May01:00pm(5 mins)
|
|
|
Lauri Paasonen | ||
| Session : Advanced Therapies in Oncology | |||||
| Room: Conference Hall | |||||
|
Wed19 May01:05pm(5 mins)
|
Luminex - A DiaSorin Company Brian Hall, Amnis Imaging Flow cytometer Product manager Title: Amnis ImageStream Machine Learning and Amnis AI Methods in Imaging Flow cytometry Data Analysis |
| Session Chair Welcome | |||||
|
Wed19 May02:10pm(5 mins)
|
|
Per-Erik Strömstedt | |||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| Bringing mesenchymal stromal cells into the clinic | |||||
|
Wed19 May02:15pm(20 mins)
|
|
Prof Katarina Leblanc | |||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| Leveraging cell and gene therapy development through DNA synthesis at scale | |||||
|
Wed19 May02:35pm(5 mins)
|
|
|
Dr Leonie Alten | ||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| Personalized tissue-engineered organs that will revolutionize future medicine | |||||
|
Wed19 May02:40pm(20 mins)
|
|
|
Dr Petter Bjorquist | ||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| Beckman Coulter Life Sciences Overview | |||||
|
Wed19 May03:00pm(5 mins)
|
|
|
Dr Maria Savino | ||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| A new platform for generating monoclonal cell lines for gene therapies with double assurance of clonality | |||||
|
Wed19 May03:05pm(5 mins)
|
|
|
Dr Elly Sinkala | ||
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
| Joint Q&A Session | |||||
|
Wed19 May03:15pm(20 mins)
|
|
Prof Katarina Leblanc |
|
Dr Petter Bjorquist | |
| Session : Therapies for other diseases | |||||
| Room: Conference Hall | |||||
